IL-1Hy2

N/A

Report date: 2023/05/22 10:16:47

Base Information

Drug NameIL-1Hy2
Drug Alias NameIL1Hy2
ClassificationBiologics
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNuvelo Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNuvelo Inc
Active IndicationsN/A
Inactive IndicationsArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A